Weekly News Wire | August 16, 2022
Oklahoma Medicaid Monitoring Value-Based Agreement For Pear Therapeutics Prescription Digital Addiction Treatment
The Oklahoma Medicaid program and Pear Therapeutics entered a value-based access agreement for Pear’s reSET and reSET-O prescription digital therapeutic (PDT) addiction treatments. The agreement went into effect on January 1, 2022. OHCA has not disclosed the specific performance and outcomes-based benchmarks being monitored under this agreement. OHCA intends to evaluate usage of the two Pear products at the end of the year. The two PDTs are 12-week programs for use by adults in outpatient addiction treatment settings under the supervision of a clinical professional.
The PDTs are available to adult beneficiaries enrolled in the . . .
Want To Read More? Log In Or Become A Paid Member
